[Radioiodine therapy for benign thyroid diseases]

Area of Science:

• Endocrinology
• Thyroidology

Context:

• Benign thyroid diseases can lead to thyrotoxicosis syndrome.
• Effective management strategies are crucial for patient outcomes.

Purpose:

• To outline the primary treatment modalities for benign thyroid diseases associated with thyrotoxicosis.
• To highlight the distinctions in treatment approaches for autoimmune versus non-immune hyperthyroidism.

Summary:

• Medication, surgery, and radioiodine therapy are the three main treatment options for benign thyroid diseases presenting with thyrotoxicosis.
• Specific considerations differentiate the management of autoimmune hyperthyroidism (e.g., Graves' disease) from non-immune hyperthyroidism (e.g., toxic nodular goiter).

Impact:

• Provides a foundational understanding of thyroid disease treatment options.
• Informs clinical decision-making by differentiating treatment strategies based on etiology.